▶ 調査レポート

世界のブルセラ症ワクチン産業2020-2026

• 英文タイトル:Global Brucellosis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界のブルセラ症ワクチン産業2020-2026 / Global Brucellosis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3011275資料のイメージです。• レポートコード:D0MA3011275
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、138ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥539,000 (USD4,900)▷ お問い合わせ
  Multi User¥808,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,078,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、ブルセラ症ワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ブルセラ症ワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(S19ワクチン、RB51ワクチン株、その他)、用途別市場規模(牛、羊、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ブルセラ症ワクチンの種類別市場2015-2026:S19ワクチン、RB51ワクチン株、その他
・ブルセラ症ワクチンの用途別市場2015-2026:牛、羊、その他
・ブルセラ症ワクチンの北米市場分析
・ブルセラ症ワクチンのアジア市場分析
・ブルセラ症ワクチンの中南米市場分析
・ブルセラ症ワクチンの中東・アフリカ市場分析
・関連企業情報:Jinyu、Colorado Serum、Boehringer Ingelheim、Biogenesis-Bago、Vetal Company、CZ Veterinaria、SYVA Laboratorios、Indian Immunologicals、Qilu、Tecnovax、Hester Biosciences、Zoetis、Onderstepoort Biological、Instituto Rosenbusch、Ceva Sante Animale、Calier & Biologicos Laverlam、Biovet
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.
The classification of Brucellosis Vaccines includes S19 Vaccine, RB51 Vaccine Strain and Other. And the proportion of S19 Vaccine in 2016 is about 86%, and the proportion is stable from 2012 to 2016.
Brucellosis Vaccines is widely used in Cattle, Sheep and Other Animal. The most proportion of Brucellosis Vaccines is for Cattle with market share about 60 in 2016.
In 2019, the global Brucellosis Vaccines market size was US$ 10 million and is forecast to US$ 13 million in 2026, growing at a CAGR of 3.7% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Brucellosis Vaccines.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Brucellosis Vaccines market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Brucellosis Vaccines market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Brucellosis Vaccines market. Readers of the report can become informed about current and future trends of the global Brucellosis Vaccines market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Brucellosis Vaccines markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Brucellosis Vaccines market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Brucellosis Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Brucellosis Vaccines market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Brucellosis Vaccines market is segmented into
S19 Vaccine
RB51 Vaccine Strain
Other

Market Segment by Application, the Brucellosis Vaccines market is segmented into
Cattle
Sheep
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Hester Biosciences
Zoetis
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet

The study objectives are:
To analyze and research the global Brucellosis Vaccines status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Brucellosis Vaccines manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Brucellosis Vaccines are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Brucellosis Vaccines Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Brucellosis Vaccines Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 S19 Vaccine
1.3.3 RB51 Vaccine Strain
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Brucellosis Vaccines Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Cattle
1.4.3 Sheep
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Brucellosis Vaccines Revenue (2015-2026)
2.1.1 Global Brucellosis Vaccines Revenue (2015-2026)
2.1.2 Global Brucellosis Vaccines Sales (2015-2026)
2.2 Brucellosis Vaccines Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Brucellosis Vaccines Sales by Regions (2015-2020)
2.2.2 Global Brucellosis Vaccines Revenue by Regions (2015-2020)
2.3 Global Top Brucellosis Vaccines Regions (Countries) Ranking by Market Size
2.4 Brucellosis Vaccines Industry Trends
2.4.1 Brucellosis Vaccines Market Top Trends
2.4.2 Market Drivers
2.4.3 Brucellosis Vaccines Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Brucellosis Vaccines Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Brucellosis Vaccines Manufacturers by Sales (2015-2020)
3.1.1 Global Brucellosis Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Brucellosis Vaccines Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Brucellosis Vaccines Sales in 2019
3.2 Global Top Manufacturers Brucellosis Vaccines by Revenue
3.2.1 Global Brucellosis Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Brucellosis Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Brucellosis Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2019)
3.4 Global Brucellosis Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Brucellosis Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Brucellosis Vaccines Market
3.7 Key Manufacturers Brucellosis Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Brucellosis Vaccines Historic Market Review by Type (2015-2020)
4.1.2 Global Brucellosis Vaccines Sales Market Share by Type (2015-2020)
4.1.3 Global Brucellosis Vaccines Revenue Market Share by Type (2015-2020)
4.1.4 Brucellosis Vaccines Price by Type (2015-2020)
4.1 Global Brucellosis Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Brucellosis Vaccines Sales Forecast by Type (2021-2026)
4.2.3 Global Brucellosis Vaccines Revenue Forecast by Type (2021-2026)
4.2.4 Brucellosis Vaccines Price Forecast by Type (2021-2026)

5 Global Brucellosis Vaccines Market Size by Application
5.1 Global Brucellosis Vaccines Historic Market Review by Application (2015-2020)
5.1.2 Global Brucellosis Vaccines Sales Market Share by Application (2015-2020)
5.1.3 Global Brucellosis Vaccines Revenue Market Share by Application (2015-2020)
5.1.4 Brucellosis Vaccines Price by Application (2015-2020)
5.2 Global Brucellosis Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Brucellosis Vaccines Sales Forecast by Application (2021-2026)
5.2.3 Global Brucellosis Vaccines Revenue Forecast by Application (2021-2026)
5.2.4 Brucellosis Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Brucellosis Vaccines Breakdown Data by Company
6.2 North America Brucellosis Vaccines Breakdown Data by Type
6.3 North America Brucellosis Vaccines Breakdown Data by Application
6.4 North America Brucellosis Vaccines Breakdown Data by Countries
6.4.1 North America Brucellosis Vaccines Sales by Countries
6.4.2 North America Brucellosis Vaccines Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Brucellosis Vaccines Breakdown Data by Company
7.2 Europe Brucellosis Vaccines Breakdown Data by Type
7.3 Europe Brucellosis Vaccines Breakdown Data by Application
7.4 Europe Brucellosis Vaccines Breakdown Data by Countries
7.4.1 Europe Brucellosis Vaccines Sales by Countries
7.4.2 Europe Brucellosis Vaccines Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Brucellosis Vaccines Breakdown Data by Company
8.2 Asia Pacific Brucellosis Vaccines Breakdown Data by Type
8.3 Asia Pacific Brucellosis Vaccines Breakdown Data by Application
8.4 Asia Pacific Brucellosis Vaccines Breakdown Data by Regions
8.4.1 Asia Pacific Brucellosis Vaccines Sales by Regions
8.4.2 Asia Pacific Brucellosis Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Brucellosis Vaccines Breakdown Data by Company
9.2 Latin America Brucellosis Vaccines Breakdown Data by Type
9.3 Latin America Brucellosis Vaccines Breakdown Data by Application
9.4 Latin America Brucellosis Vaccines Breakdown Data by Countries
9.4.1 Latin America Brucellosis Vaccines Sales by Countries
9.4.2 Latin America Brucellosis Vaccines Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Brucellosis Vaccines Breakdown Data by Type
10.2 Middle East and Africa Brucellosis Vaccines Breakdown Data by Application
10.3 Middle East and Africa Brucellosis Vaccines Breakdown Data by Countries
10.3.1 Middle East and Africa Brucellosis Vaccines Sales by Countries
10.3.2 Middle East and Africa Brucellosis Vaccines Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Jinyu
11.1.1 Jinyu Corporation Information
11.1.2 Jinyu Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Jinyu Brucellosis Vaccines Products and Services
11.1.5 Jinyu SWOT Analysis
11.1.6 Jinyu Recent Developments
11.2 Colorado Serum
11.2.1 Colorado Serum Corporation Information
11.2.2 Colorado Serum Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Colorado Serum Brucellosis Vaccines Products and Services
11.2.5 Colorado Serum SWOT Analysis
11.2.6 Colorado Serum Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Brucellosis Vaccines Products and Services
11.3.5 Boehringer Ingelheim SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Biogenesis-Bago
11.4.1 Biogenesis-Bago Corporation Information
11.4.2 Biogenesis-Bago Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Biogenesis-Bago Brucellosis Vaccines Products and Services
11.4.5 Biogenesis-Bago SWOT Analysis
11.4.6 Biogenesis-Bago Recent Developments
11.5 Vetal Company
11.5.1 Vetal Company Corporation Information
11.5.2 Vetal Company Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Vetal Company Brucellosis Vaccines Products and Services
11.5.5 Vetal Company SWOT Analysis
11.5.6 Vetal Company Recent Developments
11.6 CZ Veterinaria
11.6.1 CZ Veterinaria Corporation Information
11.6.2 CZ Veterinaria Business Overview and Total Revenue (2019 VS 2018)
11.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 CZ Veterinaria Brucellosis Vaccines Products and Services
11.6.5 CZ Veterinaria SWOT Analysis
11.6.6 CZ Veterinaria Recent Developments
11.7 SYVA Laboratorios
11.7.1 SYVA Laboratorios Corporation Information
11.7.2 SYVA Laboratorios Business Overview and Total Revenue (2019 VS 2018)
11.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 SYVA Laboratorios Brucellosis Vaccines Products and Services
11.7.5 SYVA Laboratorios SWOT Analysis
11.7.6 SYVA Laboratorios Recent Developments
11.8 Indian Immunologicals
11.8.1 Indian Immunologicals Corporation Information
11.8.2 Indian Immunologicals Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Indian Immunologicals Brucellosis Vaccines Products and Services
11.8.5 Indian Immunologicals SWOT Analysis
11.8.6 Indian Immunologicals Recent Developments
11.9 Qilu
11.9.1 Qilu Corporation Information
11.9.2 Qilu Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Qilu Brucellosis Vaccines Products and Services
11.9.5 Qilu SWOT Analysis
11.9.6 Qilu Recent Developments
11.10 Tecnovax
11.10.1 Tecnovax Corporation Information
11.10.2 Tecnovax Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Tecnovax Brucellosis Vaccines Products and Services
11.10.5 Tecnovax SWOT Analysis
11.10.6 Tecnovax Recent Developments
11.11 Hester Biosciences
11.11.1 Hester Biosciences Corporation Information
11.11.2 Hester Biosciences Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Hester Biosciences Brucellosis Vaccines Products and Services
11.11.5 Hester Biosciences SWOT Analysis
11.11.6 Hester Biosciences Recent Developments
11.12 Zoetis
11.12.1 Zoetis Corporation Information
11.12.2 Zoetis Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Zoetis Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Zoetis Brucellosis Vaccines Products and Services
11.12.5 Zoetis SWOT Analysis
11.12.6 Zoetis Recent Developments
11.13 Onderstepoort Biological
11.13.1 Onderstepoort Biological Corporation Information
11.13.2 Onderstepoort Biological Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Onderstepoort Biological Brucellosis Vaccines Products and Services
11.13.5 Onderstepoort Biological SWOT Analysis
11.13.6 Onderstepoort Biological Recent Developments
11.14 Instituto Rosenbusch
11.14.1 Instituto Rosenbusch Corporation Information
11.14.2 Instituto Rosenbusch Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Instituto Rosenbusch Brucellosis Vaccines Products and Services
11.14.5 Instituto Rosenbusch SWOT Analysis
11.14.6 Instituto Rosenbusch Recent Developments
11.15 Ceva Sante Animale
11.15.1 Ceva Sante Animale Corporation Information
11.15.2 Ceva Sante Animale Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Ceva Sante Animale Brucellosis Vaccines Products and Services
11.15.5 Ceva Sante Animale SWOT Analysis
11.15.6 Ceva Sante Animale Recent Developments
11.16 Calier & Biologicos Laverlam
11.16.1 Calier & Biologicos Laverlam Corporation Information
11.16.2 Calier & Biologicos Laverlam Business Overview and Total Revenue (2019 VS 2018)
11.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Products and Services
11.16.5 Calier & Biologicos Laverlam SWOT Analysis
11.16.6 Calier & Biologicos Laverlam Recent Developments
11.17 Biovet
11.17.1 Biovet Corporation Information
11.17.2 Biovet Business Overview and Total Revenue (2019 VS 2018)
11.17.3 Biovet Brucellosis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.17.4 Biovet Brucellosis Vaccines Products and Services
11.17.5 Biovet SWOT Analysis
11.17.6 Biovet Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Brucellosis Vaccines Sales Channels
12.2.2 Brucellosis Vaccines Distributors
12.3 Brucellosis Vaccines Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Brucellosis Vaccines Sales Forecast (2021-2026)
13.1.1 Global Brucellosis Vaccines Sales Forecast by Regions (2021-2026)
13.1.2 Global Brucellosis Vaccines Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Brucellosis Vaccines Sales Forecast (2021-2026)
13.2.2 North America Brucellosis Vaccines Revenue Forecast (2021-2026)
13.2.3 North America Brucellosis Vaccines Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Brucellosis Vaccines Sales Forecast (2021-2026)
13.3.2 Europe Brucellosis Vaccines Revenue Forecast (2021-2026)
13.3.3 Europe Brucellosis Vaccines Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Brucellosis Vaccines Sales Forecast (2021-2026)
13.4.2 Asia Pacific Brucellosis Vaccines Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Brucellosis Vaccines Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Brucellosis Vaccines Sales Forecast (2021-2026)
13.5.2 Latin America Brucellosis Vaccines Revenue Forecast (2021-2026)
13.5.3 Latin America Brucellosis Vaccines Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Brucellosis Vaccines Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Brucellosis Vaccines Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Brucellosis Vaccines Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Brucellosis Vaccines Key Market Segments
Table 2. Ranking of Global Top Brucellosis Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Brucellosis Vaccines Market Size Growth Rate by Type 2021-2026 (M Doses) & (Million US$)
Table 4. Major Manufacturers of S19 Vaccine
Table 5. Major Manufacturers of RB51 Vaccine Strain
Table 6. Major Manufacturers of Other
Table 7. Global Brucellosis Vaccines Market Share by Application 2019-2025 (M Doses)
Table 8. Global Brucellosis Vaccines Market Size by Regions 2015-2020 (M Doses) & (Million US$)
Table 9. Global Brucellosis Vaccines Sales by Regions 2015-2020 (M Doses)
Table 10. Global Brucellosis Vaccines Sales Market Share by Regions 2015-2020
Table 11. Global Brucellosis Vaccines Revenue by Regions 2015-2020 (Million US$)
Table 12. Global Brucellosis Vaccines Revenue Market Share by Regions 2015-2020
Table 13. Top Brucellosis Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 14. Market Top Trends
Table 15. Brucellosis Vaccines Key Drivers: Impact Analysis (2021-2026)
Table 16. Brucellosis Vaccines Key Challenges
Table 17. Main Points Interviewed from Key Brucellosis Vaccines Players: Views for Future
Table 18. Global Brucellosis Vaccines Sales by Manufacturers (2015-2020) (M Doses)
Table 19. Global Brucellosis Vaccines Sales Share by Manufacturers (2015-2020)
Table 20. Brucellosis Vaccines Revenue by Manufacturers (2015-2020) (Million US$)
Table 21. Brucellosis Vaccines Revenue Share by Manufacturers (2015-2020)
Table 22. Global Brucellosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2019)
Table 24. Key Manufacturers Brucellosis Vaccines Average Selling Price (ASP) (2015-2020) (USD/K Doses)
Table 25. Key Manufacturers Brucellosis Vaccines Plants/Factories Distribution
Table 26. Key Manufacturers Brucellosis Vaccines Area Served
Table 27. Date of Key Manufacturers Enter into Brucellosis Vaccines Market
Table 28. Key Manufacturers Brucellosis Vaccines Product Type
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global S19 Vaccine Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 31. Global RB51 Vaccine Strain Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 32. Global Other Sales ana Revenue (2015-2020) (M Doses) & (Million US$)
Table 33. Global Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 34. Global Brucellosis Vaccines Sales Share by Type (2015-2020)
Table 35. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 36. Global Brucellosis Vaccines Price (M Doses) by Type (2015-2020)
Table 37. Global Brucellosis Vaccines Sales (M Doses) by Type (2021-2026)
Table 38. Global Brucellosis Vaccines Sales Share by Type (2021-2026)
Table 39. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 40. Global Brucellosis Vaccines Revenue Share by Type (2021-2026)
Table 41. Global Brucellosis Vaccines Price (M Doses) by Type (2021-2026)
Table 42. Global Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 43. Global Brucellosis Vaccines Sales Share by Application (2015-2020)
Table 44. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 45. Global Brucellosis Vaccines Price by Application 2015-2020 (USD/K Doses)
Table 46. Global Brucellosis Vaccines Sales by Application (2015-2020) (M Doses)
Table 47. Global Brucellosis Vaccines Sales Share by Application (2015-2020)
Table 48. Global Brucellosis Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 49. Global Brucellosis Vaccines Revenue Share by Application (2021-2026)
Table 50. Global Brucellosis Vaccines Price (M Doses) by Application (2021-2026)
Table 51. North America Brucellosis Vaccines Sales by Company (2015-2020) (M Doses)
Table 52. North America Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 53. North America Brucellosis Vaccines Sales by Type (2015-2020) (M Doses)
Table 54. North America Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 55. North America Brucellosis Vaccines Sales by Application (2015-2020) (M Doses)
Table 56. North America Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 57. North America Brucellosis Vaccines Sales by Countries (2015-2020) (M Doses)
Table 58. North America Brucellosis Vaccines Sales Market Share by Countries (2015-2020)
Table 59. North America Brucellosis Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 60. North America Brucellosis Vaccines Revenue Market Share by Countries (2015-2020)
Table 61. Europe Brucellosis Vaccines Sales by Company (2015-2020) (M Doses)
Table 62. Europe Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 63. Europe Brucellosis Vaccines Sales by Type (2015-2020) (M Doses)
Table 64. Europe Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 65. Europe Brucellosis Vaccines Sales by Application (2015-2020) (M Doses)
Table 66. Europe Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 67. Europe Brucellosis Vaccines Sales by Countries (2015-2020) (M Doses)
Table 68. Europe Brucellosis Vaccines Sales Market Share by Countries (2015-2020)
Table 69. Europe Brucellosis Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 70. Europe Brucellosis Vaccines Revenue Market Share by Countries (2015-2020)
Table 71. Asia Pacific Brucellosis Vaccines Sales by Regions (2015-2020) (M Doses)
Table 72. Asia Pacific Brucellosis Vaccines Sales Market Share by Regions (2015-2020)
Table 73. Asia Pacific Brucellosis Vaccines Sales by Type (2015-2020) (M Doses)
Table 74. Asia Pacific Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 75. Asia Pacific Brucellosis Vaccines Sales by Application (2015-2020) (M Doses)
Table 76. Asia Pacific Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 77. Asia Pacific Brucellosis Vaccines Sales by Countries (2015-2020) (M Doses)
Table 78. Asia Pacific Brucellosis Vaccines Sales Market Share by Regions (2015-2020)
Table 79. Asia Pacific Brucellosis Vaccines Revenue by Regions (2015-2020) (Million US$)
Table 80. Asia Pacific Brucellosis Vaccines Revenue Market Share by Regions (2015-2020)
Table 81. Latin America Brucellosis Vaccines Sales by Company (2015-2020) (M Doses)
Table 82. Latin America Brucellosis Vaccines Sales Market Share by Company (2015-2020)
Table 83. Latin America Brucellosis Vaccines Sales by Type (2015-2020) (M Doses)
Table 84. Latin America Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 85. Latin America Brucellosis Vaccines Sales by Application (2015-2020) (M Doses)
Table 86. Latin America Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 87. Latin America Brucellosis Vaccines Sales by Countries (2015-2020) (M Doses)
Table 88. Latin America Brucellosis Vaccines Sales Market Share by Countries (2015-2020)
Table 89. Latin America Brucellosis Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 90. Latin America Brucellosis Vaccines Revenue Market Share by Countries (2015-2020)
Table 91. Middle East and Africa Brucellosis Vaccines Sales by Type (2015-2020) (M Doses)
Table 92. Middle East and Africa Brucellosis Vaccines Sales Market Share by Type (2015-2020)
Table 93. Middle East and Africa Brucellosis Vaccines Sales by Application (2015-2020) (M Doses)
Table 94. Middle East and Africa Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 95. Middle East and Africa Brucellosis Vaccines Sales by Countries (2015-2020) (M Doses)
Table 96. Middle East and Africa Brucellosis Vaccines Sales Market Share by Countries (2015-2020)
Table 97. Middle East and Africa Brucellosis Vaccines Revenue by Countries (2015-2020) (Million US$)
Table 98. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Countries (2015-2020)
Table 99. Jinyu Company Details
Table 100. Jinyu Description and Business Overview
Table 101. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 102. Jinyu Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 103. Jinyu Brucellosis Vaccines Sales Market Share in Global Market
Table 104. Jinyu Recent Development
Table 105. Colorado Serum Company Details
Table 106. Colorado Serum Description and Business Overview
Table 107. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 108. Colorado Serum Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 109. Colorado Serum Brucellosis Vaccines Sales Market Share in Global Market
Table 110. Colorado Serum Recent Development
Table 111. Boehringer Ingelheim Company Details
Table 112. Boehringer Ingelheim Description and Business Overview
Table 113. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 114. Boehringer Ingelheim Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 115. Boehringer Ingelheim Brucellosis Vaccines Sales Market Share in Global Market
Table 116. Boehringer Ingelheim Recent Development
Table 117. Biogenesis-Bago Company Details
Table 118. Biogenesis-Bago Description and Business Overview
Table 119. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 120. Biogenesis-Bago Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 121. Biogenesis-Bago Brucellosis Vaccines Sales Market Share in Global Market
Table 122. Biogenesis-Bago Recent Development
Table 123. Vetal Company Company Details
Table 124. Vetal Company Description and Business Overview
Table 125. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 126. Vetal Company Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 127. Vetal Company Brucellosis Vaccines Sales Market Share in Global Market
Table 128. Vetal Company Recent Development
Table 129. CZ Veterinaria Company Details
Table 130. CZ Veterinaria Description and Business Overview
Table 131. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 132. CZ Veterinaria Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 133. CZ Veterinaria Brucellosis Vaccines Sales Market Share in Global Market
Table 134. CZ Veterinaria Recent Development
Table 135. SYVA Laboratorios Company Details
Table 136. SYVA Laboratorios Description and Business Overview
Table 137. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 138. SYVA Laboratorios Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 139. SYVA Laboratorios Brucellosis Vaccines Sales Market Share in Global Market
Table 140. SYVA Laboratorios Recent Development
Table 141. Indian Immunologicals Company Details
Table 142. Indian Immunologicals Description and Business Overview
Table 143. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 144. Indian Immunologicals Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 145. Indian Immunologicals Brucellosis Vaccines Sales Market Share in Global Market
Table 146. Indian Immunologicals Recent Development
Table 147. Qilu Company Details
Table 148. Qilu Description and Business Overview
Table 149. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 150. Qilu Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 151. Qilu Brucellosis Vaccines Sales Market Share in Global Market
Table 152. Qilu Recent Development
Table 153. Tecnovax Company Details
Table 154. Tecnovax Description and Business Overview
Table 155. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 156. Tecnovax Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 157. Tecnovax Brucellosis Vaccines Sales Market Share in Global Market
Table 158. Tecnovax Recent Development
Table 159. Hester Biosciences Company Details
Table 160. Hester Biosciences Description and Business Overview
Table 161. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 162. Hester Biosciences Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 163. Hester Biosciences Brucellosis Vaccines Sales Market Share in Global Market
Table 164. Hester Biosciences Recent Development
Table 165. Zoetis Company Details
Table 166. Zoetis Description and Business Overview
Table 167. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 168. Zoetis Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 169. Zoetis Brucellosis Vaccines Sales Market Share in Global Market
Table 170. Zoetis Recent Development
Table 171. Onderstepoort Biological Company Details
Table 172. Onderstepoort Biological Description and Business Overview
Table 173. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 174. Onderstepoort Biological Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 175. Onderstepoort Biological Brucellosis Vaccines Sales Market Share in Global Market
Table 176. Onderstepoort Biological Recent Development
Table 177. Instituto Rosenbusch Company Details
Table 178. Instituto Rosenbusch Description and Business Overview
Table 179. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 180. Instituto Rosenbusch Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 181. Instituto Rosenbusch Brucellosis Vaccines Sales Market Share in Global Market
Table 182. Instituto Rosenbusch Recent Development
Table 183. Ceva Sante Animale Company Details
Table 184. Ceva Sante Animale Description and Business Overview
Table 185. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 186. Ceva Sante Animale Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 187. Ceva Sante Animale Brucellosis Vaccines Sales Market Share in Global Market
Table 188. Ceva Sante Animale Recent Development
Table 189. Calier & Biologicos Laverlam Company Details
Table 190. Calier & Biologicos Laverlam Description and Business Overview
Table 191. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 192. Calier & Biologicos Laverlam Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 193. Calier & Biologicos Laverlam Brucellosis Vaccines Sales Market Share in Global Market
Table 194. Calier & Biologicos Laverlam Recent Development
Table 195. Biovet Company Details
Table 196. Biovet Description and Business Overview
Table 197. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 198. Biovet Brucellosis Vaccines Sales Growth Rate (2015-2020)
Table 199. Biovet Brucellosis Vaccines Sales Market Share in Global Market
Table 200. Biovet Recent Development
Table 201. Brucellosis Vaccines Distributors List
Table 202. Brucellosis Vaccines Customers List
Table 203. Global Brucellosis Vaccines Sales Forecast 2021-2026 (M Doses) & (Million US$)
Table 204. Global Brucellosis Vaccines Sales Forecast by Type 2021-2026 (M Doses)
Table 205. Global Brucellosis Vaccines Sales Forecast by Application 2021-2026 (M Doses)
Table 206. Global Brucellosis Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 207. Global Brucellosis Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 208. North America Brucellosis Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 209. North America Brucellosis Vaccines Revenue Forecast by Countries 2021-2026
Table 210. Europe Brucellosis Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 211. Europe Brucellosis Vaccines Revenue Market Share Forecast by Countries 2021-2026
Table 212. Asia Pacific Brucellosis Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 213. Asia Pacific Brucellosis Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 214. Latin America Brucellosis Vaccines Sales Forecast by Countries 2021-2026 (M Doses)
Table 215. Latin America Brucellosis Vaccines Revenue Forecast by Countries 2021-2026 (Million US$)
Table 216. Middle East and Africa Brucellosis Vaccines Sales Forecast by Regions 2021-2026 (M Doses)
Table 217. Middle East and Africa Brucellosis Vaccines Revenue Forecast by Regions 2021-2026 (Million US$)
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucellosis Vaccines Product Picture
Figure 2. Global Brucellosis Vaccines Sales Market Shar by Type 2015-2026
Figure 3. S19 Vaccine Figures
Figure 4. RB51 Vaccine Strain Figures
Figure 5. Other Figures
Figure 6. Global Brucellosis Vaccines Sales Market Share by Application in 2019 & 2026
Figure 7. Cattle Use Case
Figure 8. Sheep Use Case
Figure 9. Other Use Case
Figure 10. Brucellosis Vaccines Report Years Considered
Figure 11. Global Brucellosis Vaccines Market Size 2015-2026 (Million US$)
Figure 12. Global Brucellosis Vaccines Sales 2015-2020 (M Doses)
Figure 13. Global Brucellosis Vaccines Market Size Market Share by Regions 2015-2020
Figure 14. Global Brucellosis Vaccines Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Brucellosis Vaccines Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucellosis Vaccines Sales in 2019
Figure 18. Brucellosis Vaccines Value Share by Manufacturers in 2019
Figure 19. Brucellosis Vaccines Revenue Share by Manufacturers In 2019
Figure 20. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Brucellosis Vaccines Revenue Share by Type (2015-2020)
Figure 22. Global Brucellosis Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Brucellosis Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Brucellosis Vaccines Revenue Share by Application (2015-2020)
Figure 25. Global Brucellosis Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Brucellosis Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 28. Canada Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 29. Europe Brucellosis Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 31. France Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 32. U.K. Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 33. Italy Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 34. Russia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 35. Asia Pacific Brucellosis Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 37. Japan Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 38. South Korea Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 39. India Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Australia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 41. Taiwan Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 42. Indonesia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 43. Thailand Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 44. Malaysia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 45. Philippines Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 46. Vietnam Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 47. Latin America Brucellosis Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Brazil Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 50. Argentina Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Middle East and Africa Brucellosis Vaccines Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 53. Saudi Arabia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 54. U.A.E Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 55. Jinyu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Colorado Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Biogenesis-Bago Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Vetal Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. CZ Veterinaria Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. SYVA Laboratorios Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Qilu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Tecnovax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Hester Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Onderstepoort Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Instituto Rosenbusch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Calier & Biologicos Laverlam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Biovet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Brucellosis Vaccines Value Chain
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Figure 75. North America Brucellosis Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 76. North America Brucellosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Europe Brucellosis Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 78. Europe Brucellosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 79. Asia Pacific Brucellosis Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 80. Asia Pacific Brucellosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 81. Latin America Brucellosis Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 82. Latin America Brucellosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 83. Middle East and Africa Brucellosis Vaccines Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 84. Middle East and Africa Brucellosis Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed